Existing investors Edwards Lifesciences and Johnson & Johnson contributed to a round that took the medical device developer's total funding to almost $105m.
Israel-based heart disease device developer V-Wave has completed a $70m series C round featuring medical device maker Edwards Lifesciences and Johnson & Johnson Innovation – JJDC, part of medical group Johnson & Johnson.
Deerfield Management led the round, which included BRM Group, the investment vehicle of the Barkat and Rakavy families, as well as Endeavour Vision, Quark Venture, Aperture Venture Partners, Pontifax, Pura Vida Investments, TriVentures, BioStar Ventures and Israel Secondary Fund.
V-Wave has created an implantable interatrial shunt device…
